The French National Cancer Institute (INCa) is?the preeminent health and science agency in charge of cancer control in France, created under the Public Health Act of 9th August 2004. It reports to the ministries for Health and for Research.
The Institute is a public interest grouping (GIP) which brings together State representatives, charities, health insurance funds, research organisations and hospital federations. These stakeholders share a common goal of reducing the incidence of avoidable cancers and the number of cancer deaths, improving the quality of life of people with cancer during and after their illness, and reducing inequalities related to cancer.
The Institute provides an?integrated approach?encompassing all cancer-control dimensions (health, scientific, social and economic) and areas of intervention (prevention, screening, care and research) for the?benefit of patients?and their relatives.
To catalyse progress, the INCa acts as an?interface?with patients, their friends and families, the healthcare system users, general public, healthcare professionals, researchers, experts and decision-makers.